Analyzing the use of artificial intelligence for the management of chronic obstructive pulmonary disease (COPD)

Please use this identifier to cite or link to this item: http://hdl.handle.net/10045/120195
Información del item - Informació de l'item - Item information
Title: Analyzing the use of artificial intelligence for the management of chronic obstructive pulmonary disease (COPD)
Authors: Ramón-Fernández, Alberto de | Ruiz-Fernandez, Daniel | Gilart, Virgilio | Marcos-Jorquera, Diego
Research Group/s: Ingeniería Bioinspirada e Informática para la Salud | Undefined
Center, Department or Service: Universidad de Alicante. Departamento de Tecnología Informática y Computación
Keywords: COPD | Artificial intelligence | Medical applications | Predictive models
Knowledge Area: Arquitectura y Tecnología de Computadores
Issue Date: 9-Nov-2021
Publisher: Elsevier
Citation: International Journal of Medical Informatics. 2022, 158: 104640. https://doi.org/10.1016/j.ijmedinf.2021.104640
Abstract: Objective: Chronic obstructive pulmonary disease (COPD) is a disease that causes airflow limitation to the lungs and has a high morbidity around the world. The objective of this study was to evaluate how artificial intelligence (AI) is being applied for the management of the disease, analyzing the objectives that are raised, the algorithms that are used and what results they offer. Methods: We conducted a scoping review following the Arksey and O'Malley (2005) and Levac et al. (2010) guidelines. Two reviewers independently searched, analyzed and extracted data from papers of five databases: Web of Science, PubMed, Scopus, Cinahl and Cochrane. To be included, the studies had to apply some AI techniques for the management of at least one stage of the COPD clinical process. In the event of any discrepancy between both reviewers, the criterion of a third reviewer prevailed. Results: 380 papers were identified through database searches. After applying the exclusion criteria, 67 papers were included in the study. The studies were of a different nature and pursued a wide range of objectives, highlighting mainly those focused on the identification, classification and prevention of the disease. Neural nets, support vector machines and decision trees were the AI algorithms most commonly used. The mean and median values of all the performance metrics evaluated were between 80% and 90%. Conclusions: The results obtained show a growing interest in the development of medical applications that manage the different phases of the COPD clinical process, especially predictive models. According to the performance shown, these models could be a useful complementary tool in the decision-making by health specialists, although more high-quality ML studies are needed to endorse the findings of this study.
URI: http://hdl.handle.net/10045/120195
ISSN: 1386-5056 (Print) | 1872-8243 (Online)
DOI: 10.1016/j.ijmedinf.2021.104640
Language: eng
Type: info:eu-repo/semantics/article
Rights: © 2021 Published by Elsevier B.V.
Peer Review: si
Publisher version: https://doi.org/10.1016/j.ijmedinf.2021.104640
Appears in Collections:INV - IBIS - Artículos de Revistas
INV - Undefined - Artículos de Revistas

Files in This Item:
Files in This Item:
File Description SizeFormat 
ThumbnailDe-Ramon-Fernandez_etal_2022_IntJMedInform_final.pdfVersión final (acceso restringido)1,51 MBAdobe PDFOpen    Request a copy


Items in RUA are protected by copyright, with all rights reserved, unless otherwise indicated.